Palisade Bio, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Palisade Bio, Inc. (PALI) is 169.91M

According to Palisade Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 169.91M. This represents a change of 23.61% compared to the average of 137.45M of the last 4 quarters.

Palisade Bio, Inc. (PALI) Historical Enterprise Value (quarterly & annually)

How has PALI Enterprise Value performed in the past?

The mean historical Enterprise Value of Palisade Bio, Inc. over the last ten years is 4.57B. The current 169.91M Enterprise Value has changed 271.42% with respect to the historical average. Over the past ten years (40 quarters), PALI's Enterprise Value was at its highest in in the June 2017 quarter at 93.05B. The Enterprise Value was at its lowest in in the September 2023 quarter at -10539582.48.

Palisade Bio, Inc. (PALI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Palisade Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Palisade Bio, Inc. (PALI) Average Enterprise Value

How has PALI Enterprise Value performed in the past?

The current Enterprise Value of Palisade Bio, Inc. (PALI) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Palisade Bio, Inc. (PALI) Enterprise Value vs. Peers

How is PALI’s Enterprise Value compared to its peers?

Palisade Bio, Inc.’s Enterprise Value is greater than Aspire Biopharma Holdings, Inc. (-11114943.00), greater than Curis, Inc. (-2448655.00), greater than Entero Therapeutics, Inc. (10.59M), greater than Processa Pharmaceuticals, Inc. (5.06M), greater than BriaCell Therapeutics Corp. (29.94M), greater than Hoth Therapeutics, Inc. (9.87M), less than Leap Therapeutics, Inc. (319.26M), greater than Citius Pharmaceuticals, Inc. (-3260916.00), greater than Dare Bioscience, Inc. (5.35M), greater than Athira Pharma, Inc. (-4335012.00),

Build a custom stock screener for Palisade Bio, Inc. (PALI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palisade Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Palisade Bio, Inc. (PALI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Palisade Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.